3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13
Prostatic Neoplasms
9
Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Cardiovascular Diseases
3
Cardiotoxicity
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Ovarian Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Kidney Neoplasms
2
Heart Failure
2
Endometrial Hyperplasia
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Venous Thrombosis
1
Urogenital Neoplasms
1
Smoking
1
Sarcoma
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Overall Survival
1
Ototoxicity
1
Interventions
Electroencephalography
2
mazdutide
1
enzalutamide
1
amlodipine, atorvastatin drug combination
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Tablets
1
Standard of Care
1
Referral and Consultation
1
Prednisone
1
Positron-Emission Tomography
1
Methods
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hormones
1
Gonadotropin-Releasing Hormone
1
Exercise
1
Ethanol
1
Drug Delivery Systems
1
Dignity Therapy
1
Decision Support Techniques
1
Atorvastatin
1
Aging
1
Activities of Daily Living
1
Accidental Falls
1
Abiraterone Acetate
1
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dementia
×
Atorvastatin
×
Clear all
NCT02099123
2024-11-21
STAREE
Monash University
Phase 4
Active not recruiting
9,971 enrolled